To include your compound in the COVID-19 Resource Center, submit it here.

Management tracks: Ultragenyx COO to step down next year; plus Agios, MiMedx, Iveric, Ardelyx, Novo Seeds, Axcella, NervGen

Rare disease company Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) said COO Wladimir Hogenhuis will step down on Jan. 10 due to personal reasons.

Cellular metabolism-focused company Agios Pharmaceuticals Inc. (NASDAQ:AGIO) hired Jonathan Biller as

Read the full 329 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers